ASMS 2018

ASMS 2018

Display:
Sort By:

Interview with Professor Michael Przybylski

ACCELLERATING BIOPHARMACEUTICAL CHARACTERIZATION

Yannick Baschung1,2; Loredana Lupu1,2; Michael Glocker2; Michael Przybylski1

1Steinbeis Analysis & Biomedical Mass Spectrometry, Rüsselsheim, Germany, 2Proteome Center, Institute of Immunology, University of Rostock, Rostock, Germany

Pascal Wiegand1,2; Nico Hüttmann1,2; Julia Wack2; Loredana Lupu1,3; Alexander Lazarev4; Katja Schmitz2 and Michael Przybylski1

1Steinbeis Centre for Biopolymer Analysis & Biomedical Mass Spectrometry, Marktstr. 29, 65428 Rüsselsheimam Main, Germany, 2Techn. University Darmstadt, Institute of Organic Chemistry and Biochemistry, Alarich-Weiss-Str. 8, 64287 Darmstadt, Germany, 3Department for Proteome Research Institute of Immunology, Medical Faculty and Natural Science Faculty University of Rostock, Germany, 4Pressure Biosciences, Inc., 14 Norfolk Avenue, South Easton, MA 02375, USA

Tatiana N. Boronina1; Lauren R. DeVine1; and Robert N. Cole1

1Mass Spectrometry and Proteomics Facility at the Department of Biological Chemistry, Johns Hopkins School of Medicine, Baltimore, MD 21205

This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it.

Shu-Hua Chen; Christine H. Parker; Timothy R. Croley; Melinda A. McFarland

Spectroscopy and Mass Spectrometry Branch, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD